BCHT Biotechnology (688276)
Overview
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company's products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.
Employees1252
Market Cap$6.1B
Revenue$590.1M
Listed OnShanghai Stock Exchange
Ticker688276
CEOMr. Chunlai Jiang
HeadquartersChangchun